Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics
Disease-causing splicing mutations can be rescued by variants of the U1 small nuclear RNA (U1snRNAs). However, the evaluation of the efficacy and safety of modified U1snRNAs as therapeutic tools is limited by the availability of cellular and animal models specific for a given mutation. Hence, we exp...
Saved in:
Main Authors: | Elena Barbon (Author), Mattia Ferrarese (Author), Laetitia van Wittenberghe (Author), Peggy Sanatine (Author), Giuseppe Ronzitti (Author), Fanny Collaud (Author), Pasqualina Colella (Author), Mirko Pinotti (Author), Federico Mingozzi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing Mutants
by: Dario Balestra, et al.
Published: (2016) -
The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery
by: Agathe Eckenfelder, et al.
Published: (2012) -
Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
by: Saskia Breuel, et al.
Published: (2019) -
Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption
by: Christoph Jüschke, et al.
Published: (2021) -
The Functionality of Minimal PiggyBac Transposons in Mammalian Cells
by: Boris Troyanovsky, et al.
Published: (2016)